GRVI
Stock ticker:
NASDAQ
NASDAQ
40 days until earnings call
Intraday data for
Jan 21, 09:30 AM (EST)
Price
$4.36
Change
+$0.06 (+1.40%)
Capitalization
$70.4m
GRVI Price Prediction, Grove Stock Technical Analysis Industry @PharmaceuticalsOther
Stock ticker: NASDAQ
GRVI
AS OF
Jan 21, 09:30 AM (EST)
Price
$4.36
Change
+$0.06 (+1.40%)
Capitalization
$70.4m
40 days until earnings call
GRVI Price Prediction, Grove Stock Technical Analysis
Stock market charts, price targets, analyst ratings and a financial calendar
Industry @PharmaceuticalsOtherA.I.dvisor published
GRVI Commentaries and news forecasts
3:00 PM EST Jan 20
GRVI (Grove): Weekly Commentary
Please wait a moment while the chart loads...
An error occurred while loading prices!
AI Screener Basics
AI Screener FA & TA
Forecasts, Signals and Predictions about GRVI (Grove)
| Technical Analysis | # Of Indicators | Avg. Odds |
|---|---|---|
| Bullish trend | | |
| Bearish trend | | |
| Bearish trend | | |
| Bullish trend | |
| Fundamental Analysis | (1 - best, 100 - worst) |
|---|
A.I.dvisor published
a Summary for GRVI with price predictions.
4:00 PM EST Jan 20
GRVI saw its Stochastic Oscillator peaks and leaves the overbought zone
The Stochastic Indicator for GRVI moved out of overbought territory on January 18, 2022. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 2 similar instances where the indicator exited the overbought zone. In
Current price $4.36 crossed the resistance line at $7.50 and is trading between $7.50 resistance and $2.51 resistance lines. Throughout the month of 12/17/21 - 01/20/22, the price experienced a +2% Uptrend, while the week of 01/12/22 - 01/20/22 shows a -3% Downtrend.
Technical Analysis, Outlook, Fundamental Analysis READ MORE...
A.I.dvisor
published General Information
General Information
Profile
Fundamentals
Details
| Address | 1710 Whitney Mesa Drive, Henderson, NV, 89014 |
| Phone | +1 701 353-5425 |
| Employees | 122 |
| Web | https://www.cbd.io |
GRVI
Select Stock attributes to show
| Capitalization | 70.4M |
| P/E Ratio | 15.90 |
| Risk (Beta) | N/A |
| Dividend Yield | N/A |
| Total Cash | 2.118M |
| Total Cash/Share | 0.13 |
| Total Debt | 3.527M |
| Total Debt/Equity | N/A |
| Projected Growth (PEG Ratio) | N/A |
| Revenue/Share (as % of the share price) | 2% |
| Revenue | 15.8M |
| ROE | N/A |
| Book Value | 3.72M |
| P/B Ratio | 2.84 |
| Cash Flow | N/A |
| Earnings | -0.034 |
| Average Daily Volume YTD | N/A |
| Common Shares Outstanding - Security Level | 12K |
| Current Ratio | 1.07 |
| Current Revenue Per Employee | 70,527.93 |
| Dividends Per Share - Security | N/A |
| EBITDA | 1.059M |
| Float | N/A |
| Float - Current | N/A |
| Gross Income Margin | 53.51 |
| Revenue To Assets | -3.94 |
| Shares Held By Institutions | 1.468M |
| Shares Outstanding - Current | N/A |
| Total Liabilities | 8.209M |
| Total Volume MTD | N/A |
| Value | Under |
| Gain YTD | 6.965 |
| Group | Domestic Stock Funds |
| Category | Pharmaceuticals |
| Total Expense Ratio | |
| Min. Initial Investment | 0.00 USD |
| Fund Existence | a few seconds ago |
| Turnover | |
| Front Load | |
| Net Assets | 0.00 USD |
| Manager Tenure |
| Group | Domestic Stock Funds | |
| Category | Pharmaceuticals | |
| Capitalization | 70.43m USD | |
| P/E Ratio | 15.898251 | |
| Total Cash | 2.12m USD | |
| Projected Growth | N/A | |
| Total Debt | 3.53m USD | |
| Revenue | 15.76m USD | |
| Risk (Beta) | N/A | |
| Dividend Yield | N/A | |
| Total Cash/Share | 0.13 | |
| Total Debt/Equity | N/A | |
| Revenue/Share | 2.00USD | as % of share price |
| Group | Domestic Stock Funds |
| Category | Pharmaceuticals |
| Net Assets | 0.00 USD |
| Fund Existence | a few seconds ago |
| Turnover | |
| Capitalization | |
| Yield | |
| Total Expense Ratio | |
| Investment Style | |
| Risk (Beta) |
| Group | Domestic Stock Funds |
| Category | Pharmaceuticals |
| Market Capitalization | 0.00 USD |
| Volume | 0.00 USD |
A.I.dvisor
published a Pattern (end of day)
GRVI:
TIME